Skip to Content

Join the 'Herpes Simplex, Mucocutaneous / Immunocompromised Host' group to help and get support from people like you.

Herpes Simplex, Mucocutaneous / Immunocompromised Host News

Genital Herpes Vaccine Shows Promise in Animal Trials

Posted 20 Jan 2017 by Drugs.com

THURSDAY, Jan. 19, 2017 – A new vaccine for genital herpes could be nearing human clinical trials, researchers say. The vaccine has proven effective in animals against herpes simplex virus 2, the sexually transmitted virus that causes genital herpes, according to a new report. The new "trivalent" vaccine targets three different parts of the virus, shutting down its ability to enter cells and to evade detection by the immune system, said senior researcher Dr. Harvey Friedman. He's a professor with the University of Pennsylvania School of Medicine's Institute for Immunology. In lab studies, the vaccine proved 98 percent effective in protecting guinea pigs against genital herpes infection, Friedman and his colleagues reported. The vaccine also promoted an immune response in monkeys, increasing the levels of antibodies targeting the virus, the study authors said. The vaccine's developers ... Read more

Related support groups: Sexually Transmitted Diseases, Cold sores, Herpes Simplex - Suppression, Herpes Simplex, Zostavax, Yellow Fever Vaccine, Gardasil, Herpes Simplex Labialis, Herpes Simplex, Mucocutaneous/Immunocompromised Host, Viral Infection, Herpes Simplex, Mucocutaneous/Immunocompetent Host, Rabies Vaccine, Human Diploid Cell, FluLaval, Hepatitis B Adult Vaccine, Varicella Virus Vaccine, Rotarix, Smallpox Vaccine, Cervarix, Measles Virus Vaccine, Human Papillomavirus Vaccine

Task Force: Routine Genital Herpes Screening Not Recommended

Posted 2 Aug 2016 by Drugs.com

TUESDAY, Aug. 2, 2016 – A U.S. federal task force is prepared to recommend that teens, adults and pregnant women not be routinely tested for genital herpes if they don't have signs of infection. About one in every six Americans between the ages of 14 and 49 has genital herpes, according to the U.S. Centers for Disease Control and Prevention. The disease, which is transmitted through vaginal, anal and oral sex, causes symptoms like blisters, discharge, burning and bleeding between periods. Though symptoms can be treated, genital herpes is incurable. In support of its proposed guidelines, the U.S. Preventive Services Task Force says the benefit of routine herpes screening is small, because early treatments aren't likely to make much of a difference. "Because there's no cure, there isn't much doctors and nurses can do for people who don't have symptoms," Dr. Maureen Phipps said in a news ... Read more

Related support groups: Sexually Transmitted Diseases, Cold sores, Herpes Simplex - Suppression, Herpes Simplex, Herpes Simplex Labialis, Herpes Simplex, Mucocutaneous/Immunocompromised Host, Herpes Simplex, Mucocutaneous/Immunocompetent Host, Herpes Simplex Otitis Externa, Herpes Simplex - Prophylaxis

New STD Report Finds Some Progress, High Costs for U.S.

Posted 23 Nov 2010 by Drugs.com

MONDAY, Nov. 22 – The approximately 19 million new sexually transmitted disease (STD) infections that occur each year in the United States cost the health care system about $16.4 billion annually, the U.S. Centers for Disease Control and Prevention said in its annual STD report released Monday. The data for 2009 shows a continued high burden of STDs but there are some signs of progress, according to the report, which focuses on chlamydia, gonorrhea and syphilis. The national rate of reported gonorrhea cases stands at 99 cases per 100,000 people, its lowest level since record keeping started in 1941, and cases are declining among all racial/ethnic groups (down 17 percent since 2006). Since 2006, chlamydia infections have increased 19 percent to about 409 per 100,000 people. However, the report suggests that this indicates more people than ever are being screened for chlamydia, which is ... Read more

Related support groups: HIV Infection, Sexually Transmitted Diseases, Chlamydia Infection, Herpes Simplex - Suppression, Trichomoniasis, Herpes Simplex, Human Papilloma Virus, Condylomata Acuminata, Syphilis, Gonococcal Infection - Uncomplicated, Herpes Simplex, Mucocutaneous/Immunocompetent Host, Herpes Simplex, Mucocutaneous/Immunocompromised Host, Herpes Simplex Encephalitis, Cervical Dysplasia, Human Papillomavirus Prophylaxis, Gonococcal Infection - Disseminated, Tertiary Syphilis, Neurosyphilis, Gonococcal Infection, Syphilis - Early

Ask a Question

Further Information

Related Condition Support Groups

Herpes Simplex

Related Drug Support Groups

Valtrex, acyclovir, valacyclovir, famciclovir, Famvir, foscarnet, Foscavir